AMBBY Financials: Ambu A/S AI Analysis



Financials

AMBBY Financial

Ambu A/S

$9.38

-0.53%

$-0.04

At close: Jun 29, 16:00:00 GMT-4

$9.38

Post-market: Jun 29, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$9.43

Open

$9.38

Day's Range

$9.38 - $9.38

52 week range

$8.54 - $16.78

Volume

500

Avg.Volume

166

Dividend yield

EPS (TTM)

0.28

Market Cap

$2.1B

What is Ambu A/S?

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	6,104	1,573	1,558	1,466	1,507	1,554
Revenue Growth (YoY)	5%	1%	3%	6%	9%	14%
Cost of Revenue	2,443	625	611	587	620	612
Gross Profit	3,661	948	947	879	887	942
Selling, General & Admin	2,642	684	689	639	630	630
Research & Development	258	91	94	39	34	35
Operating Expenses	3,007	775	783	732	717	718
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	620	157	153	150	160	208
Income Tax Expense	143	36	35	35	37	20
Net Income	477	121	118	115	123	188
Net Income Growth	28.99%	-36%	-36%	-185%	-8%	31%
Shares Outstanding (Diluted)	263.04	263.04	268.18	264.82	267.39	264.78
Shares Change (YoY)	-1%	-1%	0%	-1%	0%	-1%
EPS (Diluted)	1.79	0.46	0.44	0.43	0.46	0.71
EPS Growth	30%	-35%	-35%	-186%	-8%	31%
Free Cash Flow	375	104	13	130	128	80
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	59.97%	60.26%	60.78%	59.95%	58.85%	60.61%
Operating Margin	10.71%	10.99%	10.52%	10.02%	11.28%	14.41%
Profit Margin	7.81%	7.69%	7.57%	7.84%	8.16%	12.09%
Free Cash Flow Margin	6.14%	6.61%	0.83%	8.86%	8.49%	5.14%
EBITDA	1,039	271	261	201	223	277
EBITDA Margin	17.02%	17.22%	16.75%	13.71%	14.79%	17.82%
D&A For EBITDA	385	98	97	54	53	53
EBIT	654	173	164	147	170	224
EBIT Margin	10.71%	10.99%	10.52%	10.02%	11.28%	14.41%
Effective Tax Rate	23.06%	22.92%	22.87%	23.33%	23.12%	9.61%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

6,104

1,573

1,558

1,466

1,507

1,554

Revenue Growth (YoY)

14%

Cost of Revenue

2,443

625

611

587

620

612

Gross Profit

3,661

948

947

879

887

942

Selling, General & Admin

2,642

684

689

639

630

Research & Development

258

Operating Expenses

3,007

775

783

732

717

718

Other Non Operating Income (Expenses)

Pretax Income

620

157

153

150

160

208

Income Tax Expense

143

Net Income

477

121

118

115

123

188

Net Income Growth

28.99%

-36%

-185%

-8%

31%

Shares Outstanding (Diluted)

263.04

268.18

264.82

267.39

264.78

Shares Change (YoY)

-1%

EPS (Diluted)

1.79

0.46

0.44

0.43

0.46

0.71

EPS Growth

30%

-35%

-186%

-8%

31%

Free Cash Flow

375

104

130

128

Free Cash Flow Per Share

Gross Margin

59.97%

60.26%

60.78%

59.95%

58.85%

60.61%

Operating Margin

10.71%

10.99%

10.52%

10.02%

11.28%

14.41%

Profit Margin

7.81%

7.69%

7.57%

7.84%

8.16%

12.09%

Free Cash Flow Margin

6.14%

6.61%

0.83%

8.86%

8.49%

5.14%

EBITDA

1,039

271

261

201

223

277

EBITDA Margin

17.02%

17.22%

16.75%

13.71%

14.79%

17.82%

D&A For EBITDA

385

EBIT

654

173

164

147

170

224

EBIT Margin

10.71%

10.99%

10.52%

10.02%

11.28%

14.41%

Effective Tax Rate

23.06%

22.92%

22.87%

23.33%

23.12%

9.61%

Follow-Up Questions

What are Ambu A/S's key financial statements?



According to the latest financial statement (Form-10K), Ambu A/S has a total asset of $0, Net loss of $0

What are the key financial ratios for AMBBY?



Ambu A/S's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Ambu A/S's revenue broken down by segment or geography?



Ambu A/S largest revenue segment is Urology, Ear-Nose-Throat, and Gastroenterology, at a revenue of 1,826,000,000 in the most earnings release.For geography, United States is the primary market for Ambu A/S, at a revenue of 2,980,000,000.

Is Ambu A/S profitable?



no, according to the latest financial statements, Ambu A/S has a net loss of $0

Does Ambu A/S have any liabilities?



no, Ambu A/S has liability of 0

How many outstanding shares for Ambu A/S?



Ambu A/S has a total outstanding shares of 0

Ambu A/S (AMBBY) Financial

AMBBY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Ambu A/S?

Ambu A/S (AMBBY) Financial

AMBBY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Ambu A/S?

AMBBY Income

Follow-Up Questions

What are Ambu A/S's key financial statements?

What are the key financial ratios for AMBBY?

How is Ambu A/S's revenue broken down by segment or geography?

Is Ambu A/S profitable?

Does Ambu A/S have any liabilities?

How many outstanding shares for Ambu A/S?